Clinical Trial Update: A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin/paclitaxel with pegfilgrastim supported by hematopoietic progenitor cell re-infusion in whole blood in patients with breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: COMPLETED